跳至主要内容
临床试验/NCT04579146
NCT04579146Unknown不适用

ROLE OF IMMUNE ACTIVATION PROFILES IN CORONARY ATHEROTHROMBOSIS IN PATIENTS HIV-1-INFECTED ON EFFECTIVE ANTIRETROVIRAL THERAPY

Hôpital Européen Marseille1 个研究点 分布在 1 个国家目标入组 60 人开始时间: 2020年9月7日最近更新:
适应症

试验速览

阶段
不适用
发起方
入组人数
60
试验地点
1
主要终点
correlation between a particular profile of immune activation in patients HIV under treatment presenting cardiovascular risk factors and the presence of coronary atheromatous plaques

研究概览

简要总结

HIV-infected patients with intermediate-high risk have a high prevalence of CAD and a substantial proportion of obstructive CAD. Degree of stenosis is associated with immunoactivation (lymphocyte and monocyte) and microbial translocation

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
45 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • HIV-infected patients >= 45 years with 2 or more CV risk factors currently on ART HIV-RNA < 50 copies >= 12 months (one blip allowed) Asymptomatic regarding cardiac symptoms (chest pain, syncope, dyspnea) Stable ART for more than 6 months

排除标准

  • Sign of coronary pathology (chest pain, syncope, dyspnea).
  • ATCD of allergy to IV contrast agents
  • Chronic inflammatory disease other than HIV
  • Subject to a measure for the protection of justice

结局指标

主要结局

correlation between a particular profile of immune activation in patients HIV under treatment presenting cardiovascular risk factors and the presence of coronary atheromatous plaques

时间窗: 24 months

Assessment of the prevalence of obstructive coronary artery disease in patients infected with HIV and asymptomatic with a 64-slice CT coronary angiography.

次要结局

  • Identify the bacterial populations constituting the intestinal microbiota in patients infected with HIV and look for a microbiotic signature in patients with subclinical atherothrombosis.(24 months)

研究者

发起方
Hôpital Européen Marseille
申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验